donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

01521 Frontage Holdings Corporation

3.230
+0.170+5.56%
Closed 06/24 16:08 CCT
High
3.280
Open
3.050
Turnover
17.83M
Low
3.050
Pre Close
3.060
Volume
5.59M
Market Cap
6.70B
P/E(TTM)
46.81
52wk High
9.180
Shares
2.07B
P/E(Static)
46.81
52wk Low
1.980
Float Cap
6.70B
Bid/Ask %
-27.57%
Historical High
9.180
Shs Float
2.07B
Volume Ratio
1.82
Historical Low
1.980
Dividend TTM
--
Div Yield TTM
--
P/B
2.69
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.27%
Amplitude
7.52%
Avg Price
3.192
Lot Size
2000
Float Cap
6.70B
Bid/Ask %
-27.57%
Historical High
9.180
Shs Float
2.07B
Volume Ratio
1.82
Historical Low
1.980
Dividend TTM
--
P/B
2.69
Dividend LFY
--
Turnover Ratio
0.27%
Amplitude
7.52%
Avg Price
3.192
Lot Size
2000
Price Forecast

No Data

News

Comment

Company Overview More
Fonda Holdings is a contract research organization (CRO) that provides comprehensive and scientific research, analysis and development services to pharmaceutical companies throughout the drug discovery and development process. Its departments include North America and China. The North American division includes laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemical services in the United States and Canada. The Chinese department includes laboratory testing, CMC, preclinical research, bioequivalent clinical and chemical services in China. Its preclinical studies include drug metabolism and pharmacokinetics (DMPK), safety, chemistry and toxicology, as well as laboratory tests, including bioanalysis and biological preparations, as well as central laboratories. Its services and solutions include candidate drug evaluation, product development, clinical services, and central laboratory and testing services.
CEO: Song Li
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...